A positive earnings surprise could amplify the "Rani stock forecast", with consensus estimates currently underestimating revenue growth potential. Insider buying reported last month further fuels confidence in upcoming financial results. We can see that insiders own shares in Rani Therapeutics Holdings, Inc.. It has a market capitalization of just US$106m, and insiders have US$4.7m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board, though we generally prefer to see bigger insider holdings. But it might be worth checking if those insiders have been selling. Session Date & Time: July 14, 2025 from 12:00 PM to 1:30 PM PT Technical analysis supports the bullish "Rani stock forecast", with Bollinger Bands showing a volatility expansion phase — often preceding large directional moves in biotech equities.